1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Egd: new trials by email Literature Review of Egd trials Research Report on Egd
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy - Barrett Esophagus, Gastroesophageal Reflux Disease | Phase 1 | Completed | University of Wisconsin, Madison | 43 | 2022-11-30 | 2026-04-07 |
| Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer Atezolizumab, Bevacizumab, External Beam Radiation Therapy - Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 85 | 2019-09-19 | 2026-10-05 |
Barrett Esophagus (1) · Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1) · Gastroesophageal Reflux (1) · Gastrointestinal Neoplasms (1)
Mayo Clinic (1) · University of Wisconsin, Madison (1)
United States (2)
David S Weinberg (1) · Lewis R. Roberts, MD, PhD (1) · Lionel Kankeu Fonkoua, MD (1)
P30CA014520 (1), R01CA274985 (1), R01CA294704 (1), UG1CA242635 (1)